1. World Health Organization . 2020. WHO Announces COVID-19 Outbreak a Pandemic. 2. Hiscott J, Alexandridi M, Muscolini M, Tassone E, Palermo E, Soultsioti M, Zevini A. The global impact of the coronavirus pandemic. Cytokine Growth Factor Rev. 2020 Jun;53:1-9. doi: 10.1016/j.cytogfr.2020.05.010. Epub 2020 May 28. PMID: 32487439; PMCID: PMC7254014. 3. https://www.worldometers.info/coronavirus/country/uzbekistan/ 4. Escher F, Pietsch H, Aleshcheva G, et al Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies. ESC Heart Fail 2020;7:24407.doi:10.1002/ehf2.12805 pmid:http://www.ncbi.nlm.nih.gov/pubmed/32529795 PubMed Google Scholar. 5. Shi S, Qin M, Shen B, et al Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020;5:8020.doi:10.1001/jamacardio.2020.0950pmid:http://www.ncbi.nlm.nih.gov/pubmed/32211816 PubMedGoogle Scholar 6. To K-W, Hung IF-N, Ip JD, Chu AW-H, Chan WM, Tam AR, et al. COVID19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. Clin infect dis. 2020; Aug 25; ciaa1275. PMID: 32840608 https://doi.org/ 10.1093/cid/ciaa1275 Online ahead of print. 7. Corman VM, Lienau J, Witzenrath M. Coronaviruses as the cause of respiratory infections. Der Internist. 2019;60(11):1136–1145. https://doi. org/10.1007/s00108-019-00671-5 8. Petrikov S.S., Ivannikov A.A., Vasilchenko M.K., Esaulenko A.N., Alidzhanova K.G. COVID-19 and Cardiovascular System: Pathophysiology, Pathomorphology, Complications, Long-Term Prognosis. Russian Sklifosovsky Journal "Emergency Medical Care". 2021;10(1):14-26. https://doi.org/10.23934/2223-9022-2021-10-1-14-26 9. Williamson E, Walker AJ, Bhaskaran K, et al.; The OpenSAFELY Collaborative. OpenSAFELY: factors associated with COVID- 19-related hospital death in the linked electronic health records of 17 million adult NHS patients. doi:10.1101/2020.05.06.20092999 10. Мамедов М. Н., Родионова Ю. и соавт. Коронавирусная инфекция с точки зрения междисциплинарного подхода. Круглый стол Кардиоваскулярная терапия и профилактика 2021;20(3):2849. 11. ESC European Society of Cardiology. ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic. Available at: https://www.escardio. org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance; Wu C., Chen X., Cai Y. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern. Med. 2020; 180 (7): 934–943. DOI: 10.1001/ jamainternmed.2020.0994. 12. В. Н. Ларина, М. Г. Головко, В. Г. Ларин Влияние коронавирусной инфекции (covid-19) на сердечно-сосудистую систему, ОБЗОР ВИРУСОЛОГИЯ-2020, DOI: 10.24075/vrgmu.2020.020 13. Fauci AS, Lane HC, Redfield RR. Covid-19: navigating the uncharted. N Engl J Med. 2020. DOI: 10.1056/NEJMe2002387. 14. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020;395(10223):470–473. pmid:31986257 15. Sabatino J, De Rosa S, Di Salvo G, Indolfi C. Impact of cardiovascular risk profile on COVID-19 outcome. A metaanalysis. PLoS ONE. 2020;15(8):e0237131. doi:10.1371/journal.pone.0237131 16. Ayoubkhani D, Khunti K, Nafilyan V, et al. Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study. BMJ Yale. 2021; medRxiv preprint doi:10.1101/2021.01.15.21249885. 17. Cowan LT, Lutsey PL, Pankow JS, Matsushita K, Ishigami J, Lakshminarayan K. Inpatient and outpatient infection as a trigger of cardiovascular disease: the ARIC study. J Am Heart Assoc. 2018; 7 (22): e009683-e009683. DOI: 10.1161/ JAHA.118.009683 18. Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811-8. doi:10.1001/ jamacardio.2020.1017. 19. Guan W.J., Ni Z.Y., Hu Y., Liang W., Ou Ch., He J. et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 2020 Feb 28. doi: 10.1056/ NEJMoa2002032 20. Wu Z., Mc Googan J.M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020. Feb 24. doi: 10.1001/jama.2020.2648. 21. Shlyakhto E. V., Konradi A. O., Arutyunov G. P., Arutyunov A. G., Bau- tin A. E., Boytsov S. A., Villevalde S. V., Grigoryeva N. Yu.,Duplyakov D. V., Zvar- tau N. E., Koziolova N. A., Lebedev D. S., Malchikova S. V., Medvedeva E. A., Mikhailov E. N., Moiseeva O. M., OrlovaYa. A., Pavlova T. V., Pevsner D. V., Petrova M. M., Rebrov A. P., Sitnikova M. Yu.,Solovyova A. E., Tarlovskaya E. I., Truk- shina M. A., Fedotov P. A., Fomin I. V., Khripun A. V., Chesnikova A. I., Shaposhnik I. I., Yavelov I. S., Yakovlev A. N. Guidelines for the diagnosis and treatment of circulatory diseases in the context of the COVID-19 pandemic. Russian Journal of Cardiology. 2020;25(3):3801. (In Russian) doi:10.15829/1560-4071-2020-3-3801. 22. Явелов Игорь Семенович Covid-19 и сердечно-сосудистые заболевания // Международный журнал сердца и сосудистых заболеваний. 2020. №27. 23. Bhatraju PK, Ghassemieh BJ, Nichols M, Kim M, Jerome KR, Nalla AK, Greninger AL, Pipavath S, Wurfel MM, Evans L, Kritek PM, West TE, Luks A, Gerbino A, Dale CR, Goldman JD, O’Mahony S, Mikacenic C.. Covid-19 in critically ill patients in the Seattle region—Case Series. N Engl J Med 2020;doi: 10.1056/NEJMoa2004500. - PMC - PubMed 24. Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, Lee M.. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA 2020;doi: 10.1001/jama.2020. - PMC - PubMed 25. Grasselli G, Pesenti A, Cecconi M.. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA 2020;doi: 10.1001/jama.2020.4031. - PubMed 26. Lambden S, Laterre PF, Levy MM, Francois B.. The SOFA score—development, utility and challenges of accurate assessment in clinical trials. Crit Care 2019;23:374. - PMC - PubMed 27. Inciardi R.M., Adamo M., Lupi L. et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur. Heart J. 2020; 41 (19): 1821– 1829. DOI: 10.1093/eurheartj/ehaa388. 28. Hendren N.S., Drazner M.H., Bozkurt B., Cooper L.T. Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation. 2020; 141 (23): 1903–1914. DOI: 10.1161/CIRCULATIONAHA.120.047349. 29. Yuhang Zhu , Wanying Xing , Hui Wang , Jun Song , Zhixia Sun , Xingzhao Li Characteristics of patients with STsegment elevated myocardial infarction (STEMI) at the initial stage of the COVID-19 pandemic: a systematic review and meta-analysis Infect Dis (Lond) 2021 Nov;53(11):865-875. DOI: 10.1080/23744235.2021.1953131.